
As one of only a very small number of providers in Australia and New Zealand producing 3D modelling and medical devices within a clinically acceptable timeframe, ACCISS has been assisting with complex surgical cases since 2018.
Since that time, they have matured into the most sophisticated and experienced clinically integrated PoC PMD facility in Queensland, providing this service to individual clinicians and clinical teams within the local tertiary public hospital system.
Our additive manufacturing workflows include fused deposition moulding/modelling (FDM) – used in surgical planning and patient eduction; and Stereolithography (SLA) resin printing – required for surgical guides, jigs and cement moulds designed to produce patient-matched joint spacers and cranioplasty implants.
The medical devices designed and manufactured at ACCISS are created using patient MRI or CT scan files. Software merges scans together to create a 3D image which can then be annotated and manipulated to enable virtual viewing of each anatomical structure in isolation and in conjunction with other bony and soft tissue structures and organ systems. The virtual model is then used to design scaffolding for 3D printing, enabling the lead clinician to better conceptualise the problem and plan a more effective solution.
ACCISS technology is able to be utilised in complex surgical planning cases across a range of specialties.
In addition, ACCISS are working on a referral base for patient-matched anatomical biomodels for the purpose of surgical correction and repair to be used by consultants, fellows, registrars and pre-trainees.
This library of biomodels can also be used in outpatient clinics to demonstrate the pathology to patients and their carers, as well as the surgical approach to be undertaken including the risks and benefits.
Specialties include:
ACCISS regularly receives referrals from external public and private centres to provide virtual and pre-operative surgical planning services.
Our services are able to be replicated via virtual integration to support a diversity of clinical teams in more remote and regional areas and it is our objective to be able to support a diversity of clinical teams via a ‘hub and spoke’ healthcare model.
